SmiLe incubator company MedVasc has closed an investment round of SEK 3 million (€2.64 million).
Olivier Le Moal Shutterstock
1846995598
Investment
The investors include several life science investors such as Life Science Invest Gamma, but also existing and new private investors.
The raised capital will mainly be used for final product development and for preparing an FDA 510(k) application for the company's anaesthesia catheter Solutio. Solutio aims to minimise the pain of implementing the golden standard methods for the treatment of varicose veins and is expected to reach the American market in 2025.
Cathrin Johansson, CEO, said: "We note that in a short time, we managed to attract the funds to reach relevant milestones for the coming developments goal for our Solutio catheter. It feels very good that we are now expanding our ownership group with new investors who are specialised in life science.”
